+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
South Korea Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others- Product Image
South Korea Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others- Product Image
New

South Korea Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • PDF Icon

    Report

  • 142 Pages
  • June 2025
  • Region: South Korea
  • GlobalData
  • ID: 6108275
Description Jump to:
The “South Korea Oncology Market Outlook to 2033” is a comprehensive databook report, covering key market data on the South Korea Oncology market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests, HER2 Tests, BRCA Tests, ALK Tests, BRAF Tests, BCR-ABL Tests and PD-L1 Tests

The South Korea Oncology Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Oncology Market.
  • Global corporate-level profiles of key companies operating within the South Korea Oncology Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

South Korea Oncology is segmented as follows:

  • Colorectal Cancer Screening Tests
  • EGFR Tests
  • KRAS Tests
  • HER2 Tests
  • BRCA Tests
  • ALK Tests
  • BRAF Tests
  • BCR-ABL Tests
  • PD-L1 Tests

Reasons to Buy

The South Korea Oncology Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Oncology Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Oncology Market, South Korea
3.1 Oncology Market, South Korea, Revenue ($m), 2018-2033
3.1.1 ALK Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.2 BCR-ABL Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.3 BRAF Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.4 BRCA Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.5 Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.6 EGFR Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.7 HER2 Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.1.8 KRAS Tests Market, South Korea, Revenue ($m), by Segment, 2018-2033
3.2 Oncology Market, South Korea, Volume (Units), 2018-2033
3.2.1 ALK Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.2 BCR-ABL Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.3 BRAF Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.4 BRCA Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.5 Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.6 EGFR Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.7 HER2 Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.2.8 KRAS Tests Market, South Korea, Volume (Units), by Segment, 2018-2033
3.3 Oncology Market, South Korea, Average Price ($) , 2018-2033
3.4 Oncology Market, South Korea, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in South Korea, Oncology Market
4.1 F. Hoffmann-La Roche Ltd
4.1.1 Company Overview
4.2 Danaher Corp
4.2.1 Company Overview
4.3 Agilent Technologies Inc
4.3.1 Company Overview
4.4 BioGenex Laboratories Inc
4.4.1 Company Overview
4.5 Eiken Chemical Co Ltd
4.5.1 Company Overview
4.6 Alfresa Pharma Corp
4.6.1 Company Overview
4.7 Amoy Diagnostics Co Ltd
4.7.1 Company Overview
4.8 HLB PanaGene Co Ltd
4.8.1 Company Overview
4.9 Hemosure Inc
4.9.1 Company Overview
4.10 Resonac Corporation
4.10.1 Company Overview
5 Oncology Market Pipeline Products
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 Gencurix to Raise USD1.4 Million in Private Placement of Shares
6.2 Venture Financing
6.2.1 Oncosoft Secures USD8.25 Million in Series B Financing
6.2.2 All Round Doctors Raises USD5.11 Million in Series A Financing
7 Recent Developments
7.1 Other Significant Developments
7.1.1 Apr 16, 2025: PODO Therapeutics Unveils Predictive Platform for Immuno-Oncology and Radiation Sensitivity at AACR 2025
7.1.2 Nov 20, 2024: SD Biosensor and the NCCD Discuss Cooperation Measures to Eradicate Infectious Diseases
7.2 Product News
7.2.1 Apr 16, 2025: PODO Therapeutics Unveils Predictive Platform for Immuno-Oncology and Radiation Sensitivity at AACR 2025
7.2.2 Apr 15, 2025: New Study Unveils Revolutionary Chip Technology for Studying Tumor Spheroid-Endothelial Interactions
7.2.3 Jun 04, 2024: Cellid Held a Corporate Briefing Session to Present Business Strategy and Vision
7.3 Strategy And Business Planning
7.3.1 Jul 03, 2024: Rafarma Pharmaceutical Updates: Creation of a Joint Research and Production Enterprise in Busan (South Korea) Between Rafarma and the Korean Pharmaceutical Company Woods Medical Care
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Oncology Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 2: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 3: BCR-ABL Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 4: BRAF Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 5: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 6: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 7: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 8: HER2 Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 9: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Table 10: Oncology Market, South Korea, Volume (Units), 2018-2033
Table 11: ALK Tests Market, South Korea, Volume (Units), 2018-2033
Table 12: BCR-ABL Tests Market, South Korea, Volume (Units), 2018-2033
Table 13: BRAF Tests Market, South Korea, Volume (Units), 2018-2033
Table 14: BRCA Tests Market, South Korea, Volume (Units), 2018-2033
Table 15: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2018-2033
Table 16: EGFR Tests Market, South Korea, Volume (Units), 2018-2033
Table 17: HER2 Tests Market, South Korea, Volume (Units), 2018-2033
Table 18: KRAS Tests Market, South Korea, Volume (Units), 2018-2033
Table 19: Oncology Market, South Korea, Average Price ($), 2018-2033
Table 20: Oncology Market, South Korea, Company Share by Revenue ($m), 2024
Table 21: Oncology Market Pipeline Products
Table 22: Gencurix to Raise USD1.4 Million in Private Placement of Shares
Table 23: Oncosoft Secures USD8.25 Million in Series B Financing
Table 24: All Round Doctors Raises USD5.11 Million in Series A Financing
Table 25: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Oncology Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 2: ALK Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 3: BCR-ABL Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 4: BRAF Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 5: BRCA Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 6: Colorectal Cancer Screening Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 7: EGFR Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 8: HER2 Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 9: KRAS Tests Market, South Korea, Revenue ($m), USD Constant, 2018-2033
Figure 10: Oncology Market, South Korea, Volume (Units), 2018-2033
Figure 11: ALK Tests Market, South Korea, Volume (Units), 2018-2033
Figure 12: BCR-ABL Tests Market, South Korea, Volume (Units), 2018-2033
Figure 13: BRAF Tests Market, South Korea, Volume (Units), 2018-2033
Figure 14: BRCA Tests Market, South Korea, Volume (Units), 2018-2033
Figure 15: Colorectal Cancer Screening Tests Market, South Korea, Volume (Units), 2018-2033
Figure 16: EGFR Tests Market, South Korea, Volume (Units), 2018-2033
Figure 17: HER2 Tests Market, South Korea, Volume (Units), 2018-2033
Figure 18: KRAS Tests Market, South Korea, Volume (Units), 2018-2033
Figure 19: Oncology Market, South Korea, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories

Related Topics

Related Reports

Mexico Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Mexico Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 132 Pages
  • Mexico
From
Brazil Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Brazil Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 133 Pages
  • Brazil
From
Italy Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Italy Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 138 Pages
  • Italy
From
Russia Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

Russia Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 135 Pages
  • Russia
From
India Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others - Product Image

India Oncology Market Outlook to 2033 - Colorectal Cancer Screening Tests, EGFR Tests, KRAS Tests and Others

  • Report
  • 141 Pages
  • India
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.